Skip to main content
. 2021 Jul 5;2021(7):CD011301. doi: 10.1002/14651858.CD011301.pub2

Comparison 39. AbobotulinumtoxinA 60 units versus placebo one cycle of treatment in glabellar lines.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
39.1 Participant assessment of success by analysing scores and scales 1   Risk Ratio (M‐H, Random, 95% CI) Totals not selected
39.1.1 4 weeks 1   Risk Ratio (M‐H, Random, 95% CI) Totals not selected
39.2 Physician assessment of success by analysing scores and scales 1   Risk Ratio (M‐H, Random, 95% CI) Totals not selected
39.2.1 4 weeks 1   Risk Ratio (M‐H, Random, 95% CI) Totals not selected